LALPATHLAB - Technical Analysis with Chart Patterns & Indicators
← Back to ListKey Parameters
⭐ Technical Rating: 3.8
Show all parameters (20 more)
🧾 Chart Verdict
Short-term entry zones would be between 1,890 - 1,920 ₹, utilizing the recent support band near the DMA at 1,851 ₹. A stop-loss order could be placed just below this support level, around 1,835 ₹. The momentum is still fairly strong given the current price and volume, but the elevated P/E suggests a potential resistance zone around 2,000 – 2,039 ₹, which would likely see increased selling pressure if breached significantly. Overall, the stock presents a moderate buying opportunity with a cautious approach due to valuation concerns.
✅ Positive
The price is currently trading above the 200-day DMA, indicating a medium-term uptrend supported by relatively strong volume. The RSI of 56.6 suggests that the stock has momentum and isn’t deeply oversold, providing further confirmation of this trend.
⚠️ Limitation
Despite the positive momentum signaled by the DMA and RSI, the high Stock P/E of 56.4 compared to an Industry PE of 36.1 indicates a premium valuation which could present resistance if growth slows down. The relatively low Debt-to-Equity ratio (0.08) doesn’t offset this elevated valuation significantly.
🏭 Industry
The diagnostics industry is generally considered stable and growing, driven by increasing healthcare awareness and demand for specialized testing services. However, competition within the sector remains intense, with established players and emerging startups vying for market share, which could be a factor in profitability.